Dad joke? Perhaps. But the 2020 reference to vision presents certain opportunities to ODs
Treating inflammation on anterior service proves to be effective post-surgery
Optometry doesn’t play a great enough role in the long-term management of chronic disease globally.
Do you ever sit back and think about eye-related proverbs?
“Onion, smoke, and women bring tears to your eyes.”
“Eyes that see do not grow old, open your eyes and see what is in front of you.”
ODs use their acumen to help patients maintain or establish the best quality of vision. They use tools of their trade to establish a diagnosis, then elaborate to patients in order to create a cooperative treatment.
We practice a few blocks from each other in a tertiary-care surgical practice and a primary-care optometry practice, respectively.
As this year seems to be moving as fast as the last, I find myself thinking of the book I read in 1999 called Business @ the Speed of Thought
ODs must sell from the exam chair. Everyone has heard it, a lot of us have tried it, but how well does it actually work?
The introduction of micro-invasive glaucoma surgery (MIGS) has helped to successfully treat glaucoma patients. Take a look at why MIGS may be a useful treatment option prior to late-stage glaucoma.
At the Rosenberg School of Optometry at the University of the Incarnate Word, fourth-years get hands-on experience in care for patients pre- and post-surgery, preparing them for real-world comanaging relationships.